CVS vs GRDN: stock comparison and AI forecast
Cvs Health Corp (CVS) and Guardian Pharmacy Services, Inc. (GRDN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CVS Cvs Health Corp
- Market Cap
- $115.43B
- P/E Ratio
- 23.8x
- Size
- large-cap
- AI Forecast
- NO CURRENT FORECAST
GRDN Guardian Pharmacy Services, Inc.
- Market Cap
- $2.56B
- P/E Ratio
- 38.9x
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CVS is 45.0 times larger than GRDN by market capitalization ($115.43B against $2.56B).
- CVS trades at 23.8 times trailing earnings, GRDN at 38.9 times.
- GRDN turns 4.5% of its revenue into net income, against 1.2% for CVS.
- CVS carries 2.18 times debt per unit of equity, against 0.76 times for GRDN.
- CVS yields 2.96% in dividends; GRDN pays none.
- Both companies share the SEC industry classification Retail-Drug Stores and Proprietary Stores.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CVS | GRDN |
|---|---|---|
| Market Cap | $115.43B | $2.56B |
| P/E Ratio | 23.81x | 38.88x |
| P/B Ratio | 1.45x | 10.43x |
| Dividend Yield | 2.96% | – |
| EPS | $3.79 | – |
| Book Value/Share | $62.32 | $3.88 |
| Revenue/Share | $324.55 | $23.10 |
| FCF/Share | $9.19 | – |
Profitability & Margins
| Metric | CVS | GRDN |
|---|---|---|
| ROE | 6.1% | 26.8% |
| ROA | 1.9% | 14.9% |
| ROIC | 5.0% | 29.5% |
| Gross Margin | 44.5% | 21.6% |
| Operating Margin | 2.0% | 5.8% |
| Net Margin | 1.2% | 4.5% |
| EBT Margin | 1.4% | 6.5% |
| Tax Rate | 15.6% | 30.6% |
Financial Health
| Metric | CVS | GRDN |
|---|---|---|
| Current Ratio | 0.87x | 1.65x |
| Quick Ratio | 0.66x | 1.33x |
| D/E Ratio | 2.18x | 0.76x |
| Financial Leverage | 3.18x | 1.81x |
| Interest Coverage | 3.0x | 33.9x |
| Working Capital | -$11.70B | $101M |
Cash Flow
| Metric | CVS | GRDN |
|---|---|---|
| Operating Cash Flow | $14.78B | $99M |
| Free Cash Flow | $11.76B | – |
| Capital Spending | -$3.02B | – |
| OCF Growth YoY | 95.3% | – |
| FCF Growth YoY | 146.0% | – |
| FCF/Sales | 2.8% | – |
| CapEx/Sales | 0.7% | – |
Operational Efficiency
| Metric | CVS | GRDN |
|---|---|---|
| Asset Turnover | 1.64x | 3.30x |
| Receivables Turnover | 10.3x | 14.1x |
| Inventory Turnover | 13.1x | 22.7x |
| Fixed Assets Turnover | 31.5x | 25.9x |
| Days Sales Outstanding | 35 days | 26 days |
| Days Inventory | 28 days | 16 days |
| Payables Period | – | 34 days |
| Cash Conversion Cycle | – | 8 days |
Income Statement
| Metric | CVS | GRDN |
|---|---|---|
| Total Revenue | $415.09B | $1.46B |
| Operating Income | $8.29B | $85M |
| Net Income | $4.89B | $66M |
| SG&A Expense | – | $231M |
| Cost of Goods Sold | $230.41B | $1.15B |
Dividend & Shareholder Information
| Metric | CVS | GRDN |
|---|---|---|
| Dividends Per Share | $2.67 | – |
| Payout Ratio | 70.5% | – |
| Shares Outstanding | 1279M | 63M |
| Net Income Growth | 7.9% | – |
| EPS Growth | -15.0% | – |
CVS vs GRDN: stock comparison and AI forecast
Which is bigger, CVS or GRDN?
CVS is 45.0 times larger than GRDN by market capitalization ($115.43B against $2.56B).
Which is cheaper on earnings, CVS or GRDN?
CVS trades at 23.8 times trailing earnings, GRDN at 38.9 times.
Which one does Intratio's AI model rank higher, CVS or GRDN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.